DiricanALeventFAlacaciogluA. Acute cardiotoxic effects of adjuvant trastuzumab treatment and its relation to oxidative stress. Angiology. 2014;65(10):944–949.
2.
TanriverdiOMeydanNBarutcaS. Long-term effect of trastuzumab on QT dispersion in adjuvant treatment for patients with Her2 receptor positive breast cancer: a pilot study. Med Oncol. 2012;29 (5):3265–3271.
CardinaleDColomboATorisssiR. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. J Clin Oncol. 2010;28(25):3910–3916.
5.
YavasOYaziciMErenOOyanB. The acute effect of trastuzumab infusion on ECG parameters in metastatic breast cancer patients. Swiss Med Wkly. 2007;137(39-40):556–558.
6.
TanriverdiOCetinD. Trastuzumab and QT dispersion. Swiss Med Wkly. 2011;141:w13257.
7.
SpectorNLBlackwellKL. Understanding the mechanisms behind trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol. 2009;27 (34):5838–5847.